296 related articles for article (PubMed ID: 21807398)
21. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters.
Hijosa-Valsero M; Matamoros V; Sidrach-Cardona R; Martín-Villacorta J; Bécares E; Bayona JM
Water Res; 2010 Jun; 44(12):3669-78. PubMed ID: 20494393
[TBL] [Abstract][Full Text] [Related]
22. An overview of pharmaceuticals and personal care products contamination along the river Somes watershed, Romania.
Moldovan Z; Schmutzer G; Tusa F; Calin R; Alder AC
J Environ Monit; 2007 Sep; 9(9):986-93. PubMed ID: 17726560
[TBL] [Abstract][Full Text] [Related]
23. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
[TBL] [Abstract][Full Text] [Related]
24. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
25. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
Sui Q; Huang J; Deng S; Chen W; Yu G
Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
[TBL] [Abstract][Full Text] [Related]
26. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
27. Serial mixed-mode cation- and anion-exchange solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Lavén M; Alsberg T; Yu Y; Adolfsson-Erici M; Sun H
J Chromatogr A; 2009 Jan; 1216(1):49-62. PubMed ID: 19054521
[TBL] [Abstract][Full Text] [Related]
28. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
[TBL] [Abstract][Full Text] [Related]
29. Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia.
Khan SJ; Wintgens T; Sherman P; Zaricky J; Schäfer AI
Water Sci Technol; 2004; 50(5):15-22. PubMed ID: 15497824
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and removal of emerging pharmaceutical, personal care compounds and caffeine tracer in municipal sewage treatment plant in Western Greece.
Stamatis NK; Konstantinou IK
J Environ Sci Health B; 2013; 48(9):800-13. PubMed ID: 23688231
[TBL] [Abstract][Full Text] [Related]
31. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
[TBL] [Abstract][Full Text] [Related]
32. Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry.
Wang C; Shi H; Adams CD; Gamagedara S; Stayton I; Timmons T; Ma Y
Water Res; 2011 Feb; 45(4):1818-28. PubMed ID: 21185051
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations.
Batt AL; Kim S; Aga DS
Chemosphere; 2007 Jun; 68(3):428-35. PubMed ID: 17316751
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment.
Nakada N; Tanishima T; Shinohara H; Kiri K; Takada H
Water Res; 2006 Oct; 40(17):3297-303. PubMed ID: 16938339
[TBL] [Abstract][Full Text] [Related]
35. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast.
Gómez MJ; Martínez Bueno MJ; Lacorte S; Fernández-Alba AR; Agüera A
Chemosphere; 2007 Jan; 66(6):993-1002. PubMed ID: 16962638
[TBL] [Abstract][Full Text] [Related]
36. Emission of artificial sweeteners, select pharmaceuticals, and personal care products through sewage sludge from wastewater treatment plants in Korea.
Subedi B; Lee S; Moon HB; Kannan K
Environ Int; 2014 Jul; 68():33-40. PubMed ID: 24695211
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of pharmaceuticals and hormones in sewage sludge.
Nieto A; Borrull F; Pocurull E; Marcé RM
Environ Toxicol Chem; 2010 Jul; 29(7):1484-9. PubMed ID: 20821597
[TBL] [Abstract][Full Text] [Related]
38. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment.
Paxéus N
Water Sci Technol; 2004; 50(5):253-60. PubMed ID: 15497855
[TBL] [Abstract][Full Text] [Related]
39. Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Busetti F; Linge KL; Heitz A
J Chromatogr A; 2009 Jul; 1216(31):5807-18. PubMed ID: 19560149
[TBL] [Abstract][Full Text] [Related]
40. Occurrence and fate of pharmaceuticals and personal care products in drinking water in southern China.
Qiao T; Yu Z; Zhang X; Au DW
J Environ Monit; 2011 Nov; 13(11):3097-103. PubMed ID: 21987209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
